New metric quantifies how social inequality drives disease outbreaks

Influenza tears through a crowded barracks. Ebola accelerates in a hospital system where beds per person have fallen far below what wealthy nations consider adequate. Some patients live; others die—not because of the virus alone, but because of where they were born, how much money they have, what neighborhood they call home.

For decades, two separate conversations have been happening in epidemiology. One stream of research has meticulously documented how social inequality shapes disease spread. Another has built mathematical models to forecast outbreaks and test different public health strategies. The two fields have rarely spoken to each other. Until now.

A new paper published in Biology Letters introduces a tool called the "structural causal influence" metric—a way to measure, with precision, how social determinants of health drive infectious disease transmission. The metric works within the standard mathematical models epidemiologists have used for generations, the kind that track susceptible people, infected people, and those who have recovered. But it adds something crucial: a quantifiable measure of how inequality itself becomes a vector for disease.

The research team, led by Brandon Ogbunu, a resident professor at the Santa Fe Institute and associate professor of ecology and evolutionary biology at Yale, worked with collaborators in epidemiology, statistics, and data science to build something deliberately simple. They rejected the temptation to embed their metric into cutting-edge artificial intelligence systems. Instead, they kept it readable. They kept it human. The goal was to make it possible for public health officials, policymakers, and community advocates to actually understand what the numbers were saying.

What the modeling reveals is sobering and clarifying at once: even when a population's overall risk of disease transmission is low, an epidemic can still erupt if it takes hold in a disadvantaged group. Crowded living conditions, limited access to vaccines, financial barriers to care—these are not peripheral details. They are central drivers of outbreak dynamics. Ignore them, and your predictions will fail when it matters most.

Ogbunu frames the finding as a call to solidarity. "The wisest public health practice is one that helps everyone prevent the spread of infection," he says. The implication is direct: protecting vulnerable populations is not charity. It is epidemiologically rational. It benefits everyone. Resources allocated to disease control in marginalized communities end up protecting the whole population—because disease does not respect neighborhood boundaries.

Sam Scarpino, a public health scientist at Northeastern University and co-author on the paper, sees the work as a model for what interdisciplinary research can accomplish when it moves beyond surface-level collaboration. "Different kinds of thinkers can come together to make a deep intellectual contribution that wouldn't otherwise be possible," he says. The framework, he suggests, could extend far beyond infectious disease—to chronic illness, pollution, climate impacts, any domain where inequality shapes health outcomes.

The practical applications are immediate. Public health decision-makers can now use the metric to weigh tradeoffs between different intervention strategies. Community advocates can point to the formula and show, with mathematical backing, that investing in their neighborhoods benefits the entire region. The data required is not exotic—it is the same information epidemiologists have been collecting for years. The difference is that now, social inequality has a place in the equation.